Bioequivalence of Two Different Polymorphs of Dabigatran Etexilate in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS
- Status
- COMPLETED
- Phase
- PHASE1